Details for Patent: 9,446,059
Which drugs does patent 9,446,059 protect, and when does it expire?
Patent 9,446,059 protects VYALEV and is included in one NDA.
This patent has seventy-two patent family members in thirty-seven countries.
Summary for Patent: 9,446,059
| Title: | Carbidopa and L-dopa prodrugs and methods of use |
| Abstract: | The present disclosure relates to (a) carbidopa prodrugs, (b) pharmaceutical combinations and compositions comprising a carbidopa prodrug and/or an L-dopa prodrug, and (c) methods of treating Parkinson's disease and associated conditions comprising administering a carbidopa prodrug and an L-dopa prodrug to a subject with Parkinson's disease. |
| Inventor(s): | Benoit CARDINAL-DAVID, Vincent S. Chan, Kassibla E. DEMPAH, Brian P. ENRIGHT, Rodger F. Henry, Raimundo HO, Ye Huang, Alexander D. HUTERS, Russell C. Klix, Scott W. KRABBE, Philip R. Kym, Yanbin Lao, Xiaochun Lou, Sean E. Mackey, Mark A. Matulenko, Peter T. Mayer, Christopher P. Miller, James Stambuli, Eric A. Voight, Zhi Wang, Geoff G. Zhang, Valentino J. Stella |
| Assignee: | AbbVie Inc |
| Application Number: | US14/919,418 |
|
Patent Claim Types: see list of patent claims | Use; Device; |
Drugs Protected by US Patent 9,446,059
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | VYALEV | foscarbidopa; foslevodopa | SOLUTION;SUBCUTANEOUS | 216962-001 | Oct 16, 2024 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | TREATMENT OF MOTOR FLUCTUATIONS IN ADULTS WITH ADVANCED PARKINSON'S DISEASE | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,446,059
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3209302 | ⤷ Start Trial | 2023C/510 | Belgium | ⤷ Start Trial |
| European Patent Office | 3209302 | ⤷ Start Trial | 301224 | Netherlands | ⤷ Start Trial |
| European Patent Office | 3209302 | ⤷ Start Trial | CA 2023 00015 | Denmark | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
